Theratechnologies Inc (THTX)
1.21
-0.01
(-0.82%)
USD |
NASDAQ |
Nov 14, 13:12
Theratechnologies Max Drawdown (5Y): 96.86% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 96.86% |
September 30, 2024 | 96.86% |
August 31, 2024 | 96.86% |
July 31, 2024 | 96.86% |
June 30, 2024 | 96.86% |
May 31, 2024 | 96.86% |
April 30, 2024 | 96.86% |
March 31, 2024 | 96.86% |
February 29, 2024 | 96.86% |
January 31, 2024 | 96.86% |
December 31, 2023 | 96.86% |
November 30, 2023 | 96.86% |
October 31, 2023 | 96.83% |
September 30, 2023 | 96.68% |
August 31, 2023 | 96.63% |
July 31, 2023 | 93.59% |
June 30, 2023 | 93.59% |
May 31, 2023 | 93.59% |
April 30, 2023 | 93.59% |
March 31, 2023 | 93.59% |
February 28, 2023 | 92.65% |
January 31, 2023 | 92.65% |
December 31, 2022 | 92.65% |
November 30, 2022 | 87.28% |
October 31, 2022 | 87.28% |
Date | Value |
---|---|
September 30, 2022 | 87.28% |
August 31, 2022 | 87.28% |
July 31, 2022 | 87.28% |
June 30, 2022 | 87.28% |
May 31, 2022 | 87.28% |
April 30, 2022 | 87.28% |
March 31, 2022 | 87.28% |
February 28, 2022 | 87.28% |
January 31, 2022 | 87.28% |
December 31, 2021 | 87.28% |
November 30, 2021 | 87.28% |
October 31, 2021 | 87.28% |
September 30, 2021 | 87.28% |
August 31, 2021 | 87.28% |
July 31, 2021 | 87.28% |
June 30, 2021 | 87.28% |
May 31, 2021 | 87.28% |
April 30, 2021 | 87.28% |
March 31, 2021 | 87.28% |
February 28, 2021 | 87.28% |
January 31, 2021 | 87.28% |
December 31, 2020 | 87.28% |
November 30, 2020 | 87.28% |
October 31, 2020 | 87.28% |
September 30, 2020 | 87.28% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
81.36%
Minimum
Feb 2020
96.86%
Maximum
Nov 2023
90.39%
Average
87.28%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
InMed Pharmaceuticals Inc | 99.95% |
Xenon Pharmaceuticals Inc | 54.01% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -60.79 |
Beta (5Y) | 1.408 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 78.17% |
Historical Sharpe Ratio (5Y) | -0.5451 |
Historical Sortino (5Y) | -0.8575 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.41% |